Bank of Nova Scotia Trust’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.3M | Buy |
118,911
+3,875
| +3% | +$371K | 0.88% | 31 |
|
|
2025
Q4 | $11.1M | Buy |
115,036
+3,367
| +3% | +$327K | 0.96% | 33 |
|
|
2025
Q3 | $10.6M | Buy |
111,669
+249
| +0.2% | +$22.9K | 0.99% | 32 |
|
|
2025
Q2 | $9.71M | Buy |
111,420
+956
| +0.9% | +$81.1K | 0.96% | 34 |
|
|
2025
Q1 | $9.93M | Buy |
110,464
+985
| +0.9% | +$88.1K | 1.06% | 34 |
|
|
2024
Q4 | $8.75M | Sell |
109,479
-1,406
| -1% | -$122K | 0.92% | 37 |
|
|
2024
Q3 | $9.98M | Buy |
110,885
+6,516
| +6% | +$548K | 1.01% | 35 |
|
|
2024
Q2 | $8.21M | Buy |
104,369
+4,294
| +4% | +$352K | 0.92% | 35 |
|
|
2024
Q1 | $8.72M | Buy |
100,075
+15,705
| +19% | +$1.34M | 0.94% | 34 |
|
|
2023
Q4 | $6.95M | Sell |
84,370
-3,892
| -4% | -$297K | 0.78% | 36 |
|
|
2023
Q3 | $6.92M | Sell |
88,262
-105
| -0.1% | -$8.79K | 0.82% | 38 |
|
|
2023
Q2 | $7.79M | Buy |
88,367
+87
| +0.1% | +$7.49K | 0.81% | 37 |
|
|
2023
Q1 | $7.12M | Sell |
88,280
-551
| -0.6% | -$44.9K | 0.78% | 37 |
|
|
2022
Q4 | $6.9M | Sell |
88,831
-654
| -0.7% | -$53K | 0.75% | 36 |
|
|
2022
Q3 | $7.23M | Sell |
89,485
-6,829
| -7% | -$614K | 0.82% | 38 |
|
|
2022
Q2 | $8.64M | Sell |
96,314
-837
| -0.9% | -$84.8K | 0.88% | 34 |
|
|
2022
Q1 | $10.8M | Sell |
97,151
-1,128
| -1% | -$119K | 0.94% | 33 |
|
|
2021
Q4 | $10.2M | Sell |
98,279
-351
| -0.4% | -$40.6K | 0.88% | 38 |
|
|
2021
Q3 | $12.4M | Sell |
98,630
-7,662
| -7% | -$992K | 1.12% | 31 |
|
|
2021
Q2 | $13.2M | Sell |
106,292
-776
| -0.7% | -$97.4K | 1.16% | 28 |
|
|
2021
Q1 | $12.6M | Sell |
107,068
-256
| -0.2% | -$30K | 1.22% | 26 |
|
|
2020
Q4 | $12.6M | Buy |
107,324
+3,994
| +4% | +$440K | 1.31% | 25 |
|
|
2020
Q3 | $10.7M | Buy |
103,330
+1,125
| +1% | +$113K | 1.32% | 28 |
|
|
2020
Q2 | $9.37M | Buy |
102,205
+1,252
| +1% | +$120K | 1.4% | 25 |
|
|
2020
Q1 | $9.1M | Sell |
100,953
-814
| -0.8% | -$86.6K | 1.36% | 25 |
|
|
2019
Q4 | $11.5M | Buy |
101,767
+1,721
| +2% | +$189K | 1.31% | 24 |
|
|
2019
Q3 | $10.9M | Sell |
100,046
-827
| -0.8% | -$86.3K | 1.28% | 25 |
|
|
2019
Q2 | $9.82M | Buy |
100,873
+2,092
| +2% | +$191K | 1.16% | 27 |
|
|
2019
Q1 | $9M | Sell |
98,781
-1,480
| -1% | -$132K | 1.1% | 30 |
|
|
2018
Q4 | $9.12M | Buy |
100,261
+1,276
| +1% | +$119K | 1.24% | 26 |
|
|
2018
Q3 | $9.74M | Sell |
98,985
-1,531
| -2% | -$142K | 1.06% | 30 |
|
|
2018
Q2 | $8.61M | Buy |
100,516
+3,756
| +4% | +$314K | 0.96% | 31 |
|
|
2018
Q1 | $7.76M | Buy |
96,760
+6,259
| +7% | +$516K | 0.91% | 30 |
|
|
2017
Q4 | $7.31M | Buy |
90,501
+50,797
| +128% | +$4.07M | 0.79% | 34 |
|
|
2017
Q3 | $3.09M | Buy |
+39,704
| New | +$3.3M | 0.33% | 54 |
|
|
2016
Q3 | – | Sell |
-5,370
| Closed | -$466K | – | 114 |
|
|
2016
Q2 | $466K | Sell |
5,370
-700
| -12% | -$56.6K | 0.06% | 78 |
|
|
2016
Q1 | $455K | Hold |
6,070
| – | – | 0.06% | 78 |
|
|
2015
Q4 | $467K | Sell |
6,070
-275
| -4% | -$20.7K | 0.07% | 79 |
|
|
2015
Q3 | $425K | Hold |
6,345
| – | – | 0.06% | 88 |
|
|
2015
Q2 | $468K | Buy |
6,345
+20
| +0.3% | +$1.53K | 0.06% | 92 |
|
|
2015
Q1 | $493K | Buy |
+6,325
| New | +$479K | 0.06% | 86 |
|
Other funds holding MDT
VCM
VPM
Bank of Nova Scotia Trust's MDT Position: Q1 2026 in Review
Bank of Nova Scotia Trust increased its Medtronic (MDT) stake by 3.4% in Q1 2026, buying an estimated $371K and bringing the position to 118,911 shares worth $10.3M. The position accounts for 0.88% of the portfolio, ranked #31.
Bank of Nova Scotia Trust first reported a position in MDT in Q1 2015 and has held it in 41 quarters since. The position peaked at $13.2M in Q2 2021. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Bank of Nova Scotia Trust held 118,911 shares of Medtronic worth $10.3M as of Q1 2026.
- Bank of Nova Scotia Trust bought 3,875 Medtronic shares in Q1 2026, an estimated $371K.
- Medtronic made up 0.88% of Bank of Nova Scotia Trust's portfolio in Q1 2026, its #31 holding.
- Bank of Nova Scotia Trust first reported a position in Medtronic in Q1 2015 and has held it in 41 quarters since.
- Bank of Nova Scotia Trust's Medtronic position peaked at $13.2M in Q2 2021.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Bank of Nova Scotia Trust's 13F filing for Q1 2026, filed 13 May 2026.